跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZACITIDINA SEACROSS 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AZACITIDINA SEACROSS 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Approved
STANDARD
AZACITIDINA SEACROSS 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Seacross Pharma (Europe) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 22, 2021
Approval ID
e0497abd7f7a7e5d
Company
Seacross Pharma (Europe) Limited
Type
Standard
Approval Details
Approval Id
e0497abd7f7a7e5d
Drug Cima Aemps Name
AZACITIDINA SEACROSS 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG
Register Number
86331
Holder Company Name
Seacross Pharma (Europe) Limited
Marketing Company Name
Sun Pharma Laboratorios S.L.
Authorization Date
2021-10-22
Dosage Form
POLVO PARA SUSPENSIÓN INYECTABLE
Dose
25 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Seacross Pharma (Europe) Limited
Active Ingredients
AZACITIDINA
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 22, 2021
Approval ID
e0497abd7f7a7e5d
Type
Standard
Back to CIMA-AEMPS Approvals